User menu

European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - first revision.

Bibliographic reference Van den Bergh, Peter ; Hadden, R D M ; Bouche, P. ; Cornblath, D R ; Hahn, A. ; et. al. European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - first revision.. In: European Journal of Neurology, Vol. 17, no. 3, p. 356-363 (2010)
Permanent URL http://hdl.handle.net/2078.1/32225
  1. Van Den Bergh Peter Y. K., Piéret Françoise, Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathy : Criteria for Primary Demyelination, 10.1002/mus.20022
  2. Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force, Neurology, 41, 617 (1991)
  3. Hughes R. A. C., Bouche P., Cornblath D. R., Evers E., Hadden R. D. M., Hahn A., Illa I., Koski C. L., Leger J. M., Nobile-Orazio E., Pollard J., Sommer C., Van den Bergh P., van Doorn P. A., van Schaik I. N., European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society, 10.1111/j.1468-1331.2006.01278.x
  4. Dyck Peter James, O'Brien Peter C., Oviatt Karen F., Dinapoli Robert P., Daube Jasper R., Bartleson John D., Mokri Bahram, Swift Thomas, Low Phillip A., Windebank Anthony J., Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment, 10.1002/ana.410110205
  5. Brainin M., Barnes M., Baron J.-C., Gilhus N. E., Hughes R., Selmaj K., Waldemar G., Guidance for the preparation of neurological management guidelines by EFNS scientific task forces - revised recommendations 2004*, 10.1111/j.1468-1331.2004.00867.x
  6. Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study, 10.1016/s1474-4422(08)70299-0
  7. Rajabally Y A, Nicolas G, Pieret F, Bouche P, Van den Bergh P Y K, Validity of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy: a multicentre European study, 10.1136/jnnp.2009.179358
  8. Koski C.L., Baumgarten M., Magder L.S., Barohn R.J., Goldstein J., Graves M., Gorson K., Hahn A.F., Hughes R.A.C., Katz J., Lewis R.A., Parry G.J., van Doorn P., Cornblath D.R., Derivation and validation of diagnostic criteria for chronic inflammatory demyelinating polyneuropathy, 10.1016/j.jns.2008.11.015
  9. Ruts L., van Koningsveld R., van Doorn P. A., Distinguishing acute-onset CIDP from Guillain-Barre syndrome with treatment related fluctuations, 10.1212/01.wnl.0000167549.09664.b8
  10. Dionne Annie, Nicolle Michael W., Hahn Angelika F., Clinical and electrophysiological parameters distinguishing acute-onset chronic inflammatory demyelinating polyneuropathy from acute inflammatory demyelinating polyneuropathy, 10.1002/mus.21480
  11. THOMAS P. K., WALKER R. W. H., RUDGE P., MORGAN-HUGHES J. A., KING R. H. M., JACOBS J. M., MILLS K. R., ORMEROD I. E. C., MURRAY N. M. F, MCDONALD W. I., CHRONIC DEMYELINATING PERIPHERAL NEUROPATHY ASSOCIATED WITH MULTIFOCAL CENTRAL NERVOUS SYSTEM DEMYELINATION, 10.1093/brain/110.1.53
  12. Zephir H, Stojkovic T, Latour P, Lacour A, de Seze J, Outteryck O, Maurage C-A, Monpeurt C, Chatelet P, Ovelacq E, Vermersch P, Relapsing demyelinating disease affecting both the central and peripheral nervous systems, 10.1136/jnnp.2006.108290
  13. Gondim F. A. A., Peripheral neuropathy in patients with inflammatory bowel disease, 10.1093/brain/awh429
  14. Smyth Shane, Menkes Daniel L., Coincident membranous glomerulonephritis and chronic inflammatory demyelinating polyradiculoneuropathy: Questioning the autoimmunity hypothesis, 10.1002/mus.20841
  15. Echaniz-Laguna, Rev Neurol (Paris), 161, 1213 (2005)
  16. Isose Sagiri, Kuwabara Satoshi, Kokubun Norito, Sato Yasunori, Mori Masahiro, Shibuya Kazumoto, Sekiguchi Yukari, Nasu Saiko, Fujimaki Yumi, Noto Yuichi, Sawai Setsu, Kanai Kazuaki, Hirata Koichi, Misawa Sonoko, , Utility of the distal compound muscle action potential duration for diagnosis of demyelinating neuropathies, 10.1111/j.1529-8027.2009.00226.x
  17. Rajabally Yusuf A., Jacob Saiju, Hbahbih Majed, Optimizing the use of electrophysiology in the diagnosis of chronic inflammatory demyelinating polyneuropathy: a study of 20 cases, 10.1111/j.1085-9489.2005.10306.x
  18. Rajabally Yusuf A., Jacob Saiju, Proximal nerve conduction studies in chronic inflammatory demyelinating polyneuropathy, 10.1016/j.clinph.2006.05.028
  19. Rajabally Yusuf A., Narasimhan Manisha, The value of sensory electrophysiology in chronic inflammatory demyelinating polyneuropathy, 10.1016/j.clinph.2007.06.014
  20. Bragg Julian A., Benatar Michael G., Sensory nerve conduction slowing is a specific marker for CIDP, 10.1002/mus.21186
  21. Sinnreich, Neurology, 63, 1662 (2004)
  22. Yiannikas Con, Vucic Steve, Utility of somatosensory evoked potentials in chronic acquired demyelinating neuropathy, 10.1002/mus.21078
  23. French CIDP Study Group, J Neurol Neurosurg Psychiatry, 79, 115 (2008)
  24. Mehndiratta, Cochrane Database Syst Rev, 3, CD002062 (2002)
  25. Hughes Richard, Bensa Si�n, Willison Hugh, Van Den Bergh Peter, Comi Giancarlo, Illa Isabel, Nobile-Orazio Eduardo, Van Doorn Pieter, Dalakas Marinos, Bojar Martin, Swan Anthony, , Randomized controlled trial of intravenous immunoglobulin versus oral prednisolone in chronic inflammatory demyelinating polyradiculoneuropathy, 10.1002/ana.1088
  26. Eftimov, Cochrane Database Syst Rev, 1, CD001797 (2009)
  27. Sabatelli Mario, Madia F., Mignogna T., Lippi G., Quaranta L., Tonali P., Pure motor chronic inflammatory demyelinating polyneuropathy, 10.1007/s004150170093
  28. Molenaar D S, van Doorn P A, Vermeulen M, Pulsed high dose dexamethasone treatment in chronic inflammatory demyelinating polyneuropathy: a pilot study., 10.1136/jnnp.62.4.388
  29. Kuitwaard Krista, van Doorn Pieter A., Newer Therapeutic Options for Chronic Inflammatory Demyelinating Polyradiculoneuropathy : , 10.2165/00003495-200969080-00004
  30. Dyck, N Engl J Med, 314, 461 (1986)
  31. Hahn A. F., Bolton C. F., Pillay N., Chalk C., Benstead T., Bril V., Shumak K., Vandervoort M. K., Feasby T. E., Plasma-exchange therapy in chronic inflammatory demyelinating polyneuropathy: A double-blind, sham-controlled, cross-over study, 10.1093/brain/119.4.1055
  32. Mehndiratta, Cochrane Database Syst Rev, 3, CD003906 (2004)
  33. Van Doorn, Neurology, 40, 209 (1990)
  34. Vermeulen M, van Doorn P A, Brand A, Strengers P F, Jennekens F G, Busch H F, Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy: a double blind, placebo controlled study., 10.1136/jnnp.56.1.36
  35. Hahn A. F., Bolton C. F., Zochodne D., Feasby T. E., Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: A double-blind, placebo-controlled, cross-over study, 10.1093/brain/119.4.1067
  36. Mendell, Neurology, 56, 445 (2001)
  37. Elovaara I., Apostolski S., van Doorn P., Gilhus N. E., Hietaharju A., Honkaniemi J., van Schaik I. N., Scolding N., Soelberg Sørensen P., Udd B., EFNS guidelines for the use of intravenous immunoglobulin in treatment of neurological diseases, 10.1111/j.1468-1331.2008.02246.x
  38. Hughes Richard AC, Donofrio Peter, Bril Vera, Dalakas Marinos C, Deng Chunqin, Hanna Kim, Hartung Hans-Peter, Latov Norman, Merkies Ingemar SJ, van Doorn Pieter A, Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial, 10.1016/s1474-4422(07)70329-0
  39. Dyck Peter James, Litchy William J., Kratz Kay M., Suarez Guillermo A., Low Phillip A., Pineda Alvaro A., Windebank Anthony J., Karnes Jeannine L., O'Brien Peter C., A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy, 10.1002/ana.410360607
  40. Dyck, Neurology, 35, 1173 (1985)
  41. Hughes, Cochrane Database Syst Rev, 4, CD003280 (2004)
  42. Hadden, Neurology, 53, 57 (1999)
  43. Vallat, Neurology, 60, S23 (2003)
  44. Gorson, Neurology, 50, 84 (1998)
  45. Merkies I.S.J., Bril V., Dalakas M. C., Deng C., Donofrio P., Hanna K., Hartung H-P, Hughes R. A.C., Latov N., van Doorn P. A., , Health-related quality-of-life improvements in CIDP with immune globulin IV 10%: The ICE Study, 10.1212/wnl.0b013e3181a0fd80
  46. Berger, Neurology, 45, 1628 (1995)
  47. Cruccu G., Anand P., Attal N., Garcia-Larrea L., Haanpaa M., Jorum E., Serra J., Jensen T. S., EFNS guidelines on neuropathic pain assessment, 10.1111/j.1468-1331.2004.00791.x